Diagnosis in jaundice: a contemporary approach

Distinguishing between obstructive and nonobstructive jaundice remains a central diagnostic challenge in clinical practice. Prior research has established that jaundice can stem from a range of causes, including biliary obstruction, liver disease, and metastatic tumors. It was already known that diagnostic imaging and invasive procedures can aid in this differentiation. However, the field lacked a clear framework for selecting the most appropriate test in a given clinical scenario. This uncertainty drove the need for a systematic review of diagnostic approaches. The limited accuracy of individual tests complicates decision-making for clinicians. No prior work had resolved how best to sequence diagnostic tools based on clinical suspicion. The introduction of newer noninvasive imaging methods has not yet been fully integrated into standard practice. A structured diagnostic flow chart could improve diagnostic efficiency and reduce unnecessary procedures.

The aim of this study is to clarify the diagnostic approach to jaundice by evaluating the strengths and limitations of available tests. The specific problem addressed is the difficulty in differentiating nonobstructive from obstructive causes of jaundice. The motivation stems from the clinical need for a reliable diagnostic algorithm. The paper proposes a flow chart to guide clinicians in selecting appropriate diagnostic tests. Clinical evaluation remains a foundational step in this process. The study emphasizes the importance of aligning test selection with the most probable diagnosis. The authors argue that diagnostic accuracy depends on proper patient stratification. This approach could reduce diagnostic delays and improve patient outcomes.

The authors review clinical evaluation methods alongside noninvasive and invasive diagnostic tests. Noninvasive techniques include ultrasound (US), computed tomography (CT), and cholangiography (CS). Invasive procedures such as percutaneous transhepatic cholangiography (PTC) and endoscopic retrograde cholangiopancreatography (ERC) are also discussed. The study evaluates the accuracy of each method in differentiating obstructive from nonobstructive jaundice. Clinical suspicion is used as a starting point for test selection. The authors suggest a diagnostic flow chart to guide clinicians. The review includes an analysis of the limitations of each test. No new data is generated; the focus is on synthesizing existing diagnostic evidence.

Clinical evaluation is identified as the first step in diagnosing jaundice. Noninvasive tests like US are recommended for patients with uncertain causes of jaundice. US has a high accuracy in detecting biliary obstruction. In cases of suspected liver metastases, US is preferred before more invasive tests. Direct cholangiography is suggested for patients with a high likelihood of obstructive jaundice. Liver biopsy is recommended for nonobstructive cases. The flow chart prioritizes US in ambiguous cases to avoid unnecessary invasive procedures. The study highlights that no single test is universally applicable, emphasizing the need for a tailored approach.

The authors propose a diagnostic flow chart to guide clinicians in jaundice management. They emphasize that clinical evaluation is essential before selecting diagnostic tests. US is highlighted as a valuable tool in uncertain cases. The study suggests that liver biopsy or direct cholangiography should follow US when needed. The accuracy of each test depends on the clinical context. The authors do not claim that any single test is definitive. They propose that a structured approach improves diagnostic efficiency. The conclusions reflect the need for a stepwise diagnostic strategy based on clinical suspicion.